Podcast

Tackling Cancer With Purpose

Author(s):

Kristie L. Kahl

This week, we spoke with former NFL coach, motivational speaker and acute promyelocytic leukemia survivor Chuck Pagano about his journey with cancer, and what has inspired him to give back following his diagnosis.

In 2012, former NFL head coach Chuck Pagano started to feel fatigued — a feeling most would associate with the long two-a-days of any given football preseason – but it was when unexplained bruises started to appear that he visited with the team’s medical staff and was eventually diagnosed with acute promyelocytic leukemia.

Since, he looks back on his journey and feels there was a reason he faced a cancer diagnosis — something he says is way bigger than football.

This week, we spoke with Chuck about his cancer journey, and why speaking with patients, advocates and health care professionals at CURE Magazine’s first-ever CLL Heroes event was so important to him.

Related Videos
Image of man with brown hair.
Image of a woman with brown shoulder-length hair, wearing a khaki colored blazer.
Image of a man wearing a black button-up shirt.
Related Content
FDA approves Ryoncil for children with GVHD.
December 18th 2024

Ryoncil Receives FDA Approval for Children With GVHD

Darlene Dobkowski, MA
This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of cross hairs on cancer in the blood.
December 16th 2024

Tecartus After Outpatient Lymphodepletion Safe, Effective in B-ALL and MCL

Chris Ryan
Outpatient lymphodepletion followed by Tecartus was found to be safe and effective in treating B-cell acute lymphoblastic leukemia and mantle cell lymphoma.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of blood test.
December 10th 2024

Venclexta Plus Mavenclad Boosts Response Rates in AML, MDS

Ariana Pelosci
The Venclexta-based regimen improved complete response rates in patients with acute myeloid leukemia and myelodysplastic syndromes.
Image of a heart monitor.
December 9th 2024

Heart Risk May Occur Less With Some BTK Inhibitors in B-Cell Blood Cancers

Ashley Chan
In patients with certain B-cell blood cancers, heart-related side effects may occur less after receiving second-generation BTK inhibitors.